Healthcare provider profile · identity verified

Tomas Perez, M.D.

Family Practice · THE VILLAGES, FL · NPI 1659442903

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1199	370
Levothyroxine Sodium	Levothyroxine Sodium	679	196
Rosuvastatin Calcium	Rosuvastatin Calcium	607	200
Lisinopril	Lisinopril	520	166
Losartan Potassium	Losartan Potassium	520	157
Amlodipine Besylate	Amlodipine Besylate	493	156
Hydrochlorothiazide	Hydrochlorothiazide	378	116
Metoprolol Succinate	Metoprolol Succinate	350	110
Omeprazole	Omeprazole	331	114
Metformin Hcl	Metformin Hcl	321	95
Trazodone Hcl	Trazodone Hcl	265	82
Tamsulosin Hcl	Tamsulosin Hcl	249	80
Eliquis	Apixaban	242	65
Pantoprazole Sodium	Pantoprazole Sodium	232	75
Escitalopram Oxalate	Escitalopram Oxalate	208	62
Gabapentin	Gabapentin	191	67
Allopurinol	Allopurinol	190	56
Simvastatin	Simvastatin	170	52
Alendronate Sodium	Alendronate Sodium	165	55
Pravastatin Sodium	Pravastatin Sodium	163	52
Metoprolol Tartrate	Metoprolol Tartrate	159	52
Metformin Hcl Er	Metformin Hcl	129	42
Potassium Chloride	Potassium Chloride	120	43
Meloxicam	Meloxicam	115	42
Ozempic	Semaglutide	112	28
Montelukast Sodium	Montelukast Sodium	106	34
Tramadol Hcl	Tramadol Hcl	103	36
Finasteride	Finasteride	96	32
Ezetimibe	Ezetimibe	92	33
Famotidine	Famotidine	92	35
Duloxetine Hcl	Duloxetine Hcl	91	29
Jardiance	Empagliflozin	90	21
Sildenafil Citrate	Sildenafil Citrate	86	35
Alprazolam	Alprazolam	81	34
Glimepiride	Glimepiride	80	26
Atenolol	Atenolol	76	21
Carvedilol	Carvedilol	76	23
Clopidogrel	Clopidogrel Bisulfate	76	31
Synthroid	Levothyroxine Sodium	72	22
Fluticasone Propionate	Fluticasone Propionate	71	28
Furosemide	Furosemide	71	26
Spironolactone	Spironolactone	66	27
Albuterol Sulfate Hfa	Albuterol Sulfate	65	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	16
Sertraline Hcl	Sertraline Hcl	60	21
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	59	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	17
Benazepril Hcl	Benazepril Hcl	56	15
Myrbetriq	Mirabegron	55	19
Venlafaxine Hcl Er	Venlafaxine Hcl	55	18
Candesartan Cilexetil	Candesartan Cilexetil	54	18
Doxazosin Mesylate	Doxazosin Mesylate	50	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	17
Prednisone	Prednisone	48	38
Chlorthalidone	Chlorthalidone	46	17
Clonazepam	Clonazepam	46	13
Pioglitazone Hcl	Pioglitazone Hcl	45	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	45	42
Zolpidem Tartrate	Zolpidem Tartrate	44	19
Ipratropium Bromide	Ipratropium Bromide	42	21
Tizanidine Hcl	Tizanidine Hcl	37	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	12
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Donepezil Hcl	Donepezil Hcl	35	14
Lovastatin	Lovastatin	35	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	32
Gemtesa	Vibegron	34	12
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	12
Paroxetine Hcl	Paroxetine Hcl	32	11
Xarelto	Rivaroxaban	32	suppressed
Colesevelam Hcl	Colesevelam Hcl	31	15
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Irbesartan	Irbesartan	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Ramipril	Ramipril	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Terazosin Hcl	Terazosin Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	15
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Primidone	Primidone	26	11
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Valsartan	Valsartan	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Methylprednisolone	Methylprednisolone	24	23
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	23	suppressed
Estradiol	Estradiol	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Diazepam	Diazepam	21	14
Enalapril Maleate	Enalapril Maleate	20	suppressed
Acyclovir	Acyclovir	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	13
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Lorazepam	Lorazepam	17	13
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nitroglycerin	Nitroglycerin	16	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	13
Folic Acid	Folic Acid	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Testosterone	Testosterone	14	suppressed
Torsemide	Torsemide	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Azithromycin	Azithromycin	11	11
Glipizide	Glipizide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error